Shanghai Junshi Financials
| 688180 Stock | 29.97 0.13 0.43% |
Operating Margin (0.57) | Profit Margin (1.01) | Return On Equity (0.27) |
Shanghai | Select Account or Indicator |
Understanding current and past Shanghai Junshi Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Shanghai Junshi's financial statements are interrelated, with each one affecting the others. For example, an increase in Shanghai Junshi's assets may result in an increase in income on the income statement.
Please note, the presentation of Shanghai Junshi's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shanghai Junshi's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Shanghai Junshi's management manipulating its earnings.
Shanghai Junshi Stock Summary
Shanghai Junshi competes with Industrial, China Construction, Bank of China, Agricultural Bank, and PetroChina. Shanghai Junshi is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE1000041Z1 |
| Business Address | Building 7, No |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.junshipharma.com |
| Phone | 86 21 6105 8800 |
You should never invest in Shanghai Junshi without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Shanghai Stock, because this is throwing your money away. Analyzing the key information contained in Shanghai Junshi's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Shanghai Junshi Key Financial Ratios
Shanghai Junshi's financial ratios allow both analysts and investors to convert raw data from Shanghai Junshi's financial statements into concise, actionable information that can be used to evaluate the performance of Shanghai Junshi over time and compare it to other companies across industries.| Revenue | 1.5 B | ||||
| Gross Profit | 1.45 B | ||||
| EBITDA | (1.61 B) | ||||
| Net Income | (2.25 B) | ||||
| Total Asset | 11.36 B |
Shanghai Junshi Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.4B | 8.0B | 11.1B | 12.6B | 11.4B | 8.3B | |
| Other Current Liab | 145.1M | 312.9M | 305.8M | 84.1M | 7.5M | 7.1M | |
| Other Liab | 73.3M | 83.5M | 123.9M | 134.0M | 154.1M | 100.4M | |
| Net Tangible Assets | 2.8B | 5.7B | 7.7B | 6.2B | 7.2B | 4.9B | |
| Retained Earnings | (2.0B) | (3.7B) | (4.4B) | (6.8B) | (9.0B) | (8.6B) | |
| Accounts Payable | 40.4M | 55.7M | 63.2M | 281.6M | 247.3M | 259.6M | |
| Cash | 1.2B | 3.4B | 3.5B | 6.0B | 3.8B | 3.3B | |
| Other Assets | 387.3M | 365.3M | 337.1M | 638.7M | 734.5M | 455.5M | |
| Long Term Debt | 744.9M | 542.2M | 490M | 839.6M | 1.2B | 660.7M | |
| Net Receivables | 172.9M | 663.3M | 1.3B | 232.7M | 479.7M | 452.5M | |
| Inventory | 180.7M | 343.4M | 484.6M | 599.0M | 538.1M | 349.6M | |
| Other Current Assets | 336.7M | 283.0M | 524.8M | 91.3M | 744.4M | 781.6M | |
| Total Liab | 1.4B | 2.2B | 2.7B | 2.8B | 4.0B | 2.2B | |
| Net Invested Capital | 3.8B | 6.6B | 8.5B | 10.7B | 8.9B | 6.8B | |
| Short Long Term Debt | 76.9M | 252.3M | 10.6M | 391.8M | 539.4M | 566.4M | |
| Total Current Assets | 1.9B | 4.7B | 5.8B | 7.2B | 5.5B | 4.5B | |
| Net Working Capital | 1.3B | 3.2B | 3.8B | 5.4B | 3.1B | 3.1B | |
| Intangible Assets | 6.3M | 31.0M | 51.8M | 110.5M | 134.4M | 141.1M | |
| Common Stock | 760.3M | 784.1M | 872.5M | 910.8M | 1.0B | 860.7M | |
| Capital Stock | 784.1M | 872.5M | 910.8M | 982.9M | 985.7M | 971.0M |
Shanghai Junshi Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | (18.9M) | (3.8M) | 135.5M | (93.1M) | 44.0M | 46.2M | |
| Net Interest Income | 15.9M | (9.1M) | (21.8M) | 31.6M | 70.4M | 73.9M | |
| Interest Income | 29.2M | 20.3M | 31.0M | 61.0M | 99.4M | 104.4M | |
| Interest Expense | 13.3M | 29.4M | 21.8M | 29.4M | 29.0M | 19.6M | |
| Total Revenue | 775.1M | 1.6B | 4.0B | 1.5B | 1.5B | 1.5B | |
| Gross Profit | 684.4M | 1.2B | 2.8B | 927.2M | 835.3M | 1.0B | |
| Operating Income | (794.4M) | (1.7B) | (684.6M) | (2.7B) | (2.5B) | (2.3B) | |
| Ebit | (806.0M) | (1.7B) | (686.1M) | (2.7B) | (2.4B) | (2.3B) | |
| Research Development | 946.1M | 1.8B | 2.1B | 2.4B | 1.9B | 1.6B | |
| Ebitda | (669.8M) | (1.5B) | (462.8M) | (2.4B) | (2.1B) | (2.0B) | |
| Cost Of Revenue | 90.7M | 372.5M | 1.3B | 526.3M | 667.3M | 458.2M | |
| Income Before Tax | (763.1M) | (1.7B) | (592.6M) | (2.7B) | (2.5B) | (2.4B) | |
| Net Income | (743.9M) | (1.7B) | (718.6M) | (2.4B) | (2.3B) | (2.2B) | |
| Income Tax Expense | (18.9M) | (3.8M) | 135.5M | (288.0M) | (259.2M) | (246.2M) | |
| Minority Interest | (2.9K) | (3.4K) | 9.6M | 196.0M | 252.3M | 264.9M |
Shanghai Junshi Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Shanghai Junshi Bios. It measures of how well Shanghai is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Shanghai Junshi brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Shanghai had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Shanghai Junshi has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (132.2M) | (167.0M) | (154.8M) | (136.4M) | (5.1M) | (5.3M) | |
| Investments | (119.6M) | (172.1M) | (1.0B) | (467.6M) | (775.1M) | (736.4M) | |
| Change In Cash | (1.5B) | 2.2B | 119.6M | 2.4B | 1.0B | 1.1B | |
| Free Cash Flow | (2.1B) | (2.1B) | (1.5B) | (2.2B) | (3.0B) | (2.9B) | |
| Depreciation | 59.8M | 146.0M | 243.7M | 293.7M | 303.2M | 171.5M | |
| Other Non Cash Items | (39.9M) | 7.3M | (12.0M) | (57.3M) | (104.4M) | (99.2M) | |
| Capital Expenditures | 862.3M | 580.5M | 901.8M | 394.0M | 714.5M | 669.9M | |
| Net Income | (743.9M) | (1.7B) | (720.9M) | (2.4B) | (2.2B) | (2.1B) | |
| End Period Cash Flow | 1.2B | 3.4B | 3.5B | 6.0B | 4.1B | 3.3B | |
| Change To Netincome | 46.8M | (31.0M) | (4.1M) | (58.6M) | (52.8M) | (50.1M) |
Shanghai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Junshi's current stock value. Our valuation model uses many indicators to compare Shanghai Junshi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shanghai Junshi competition to find correlations between indicators driving Shanghai Junshi's intrinsic value. More Info.Shanghai Junshi Biosciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai Junshi by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai Junshi's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shanghai Junshi Bios Systematic Risk
Shanghai Junshi's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shanghai Junshi volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Shanghai Junshi Bios correlated with the market. If Beta is less than 0 Shanghai Junshi generally moves in the opposite direction as compared to the market. If Shanghai Junshi Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shanghai Junshi Bios is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shanghai Junshi is generally in the same direction as the market. If Beta > 1 Shanghai Junshi moves generally in the same direction as, but more than the movement of the benchmark.
Shanghai Junshi Biosciences Total Assets Over Time
Shanghai Junshi December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shanghai Junshi help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shanghai Junshi Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shanghai Junshi Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Shanghai Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shanghai Junshi's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.7 | |||
| Information Ratio | 0.0828 | |||
| Maximum Drawdown | 22.42 | |||
| Value At Risk | (3.92) | |||
| Potential Upside | 5.91 |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Junshi's price analysis, check to measure Shanghai Junshi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Junshi is operating at the current time. Most of Shanghai Junshi's value examination focuses on studying past and present price action to predict the probability of Shanghai Junshi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Junshi's price. Additionally, you may evaluate how the addition of Shanghai Junshi to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |